EMEA-000876-PIP03-14-M01

  • Email
  • Help

Overview

Product details for Soliris
Invented nameSoliris
Active substance

Eculizumab

Decision numberP/0375/2017
PIP numberEMEA-000876-PIP03-14-M01
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of neuromyelitis optica spectrum disorders

Route(s) of administrationIntravenous use
PIP applicant

Alexion Europe SAS
Tel. +33 153643800
E-mail: pip.enquiries.eu@alexion.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision